Multicenter Evaluation of Lyophilized and Deep-frozen Plasmas for Assignment of the International Normalized Ratio

Summary

The interlaboratory variation of the International Normalized Ratio (INR) in various external quality assessment schemes is still relatively high. This is partly caused by inaccuracy of manufacturers’ stated International Sensitivity Index (ISI) and/or local instrumentation effects. The interlaboratory variation and accuracy of INR determinations may be improved by a local calibration procedure based on lyophilized plasmas with assigned INRs. The purpose of the present study was to determine INR values for different types of lyophilized plasmas to be used for local calibration. A total of 13 lyophilized plasmas (one normal, six from coumarin-treated patients, six artificially depleted) were analyzed by 10 laboratories, each using five calibrated prothrombin time (PT) systems. INRs were calculated for each plasma using each laboratory’s specific ISI and mean normal prothrombin time values. In the same way, five deep-frozen pooled plasmas from coumarin-treated patients were analyzed. There were significant INR differences for the lyophilized plasmas between the prothrombin time systems. The differences were relatively small for the deep-frozen coumarin plasmas (CV 2.6-3.3%) and three lyophilized coumarin plasmas from one manufacturer (CV 3.7-4.8%). Important INR differences were observed for three lyophilized coumarin plasmas from another manufacturer (CV 9.5-14.1%) and several artificially depleted plasmas (CV 5.3-12.8%). The citrate concentrations in the artificially depleted plasmas were lower than those in the normal and coumarin plasmas. These differences should be considered in the selection and certification of plasmas as calibrants for local calibration of PT systems. The lyophilized plasmas’ INR values obtained in the present study will be used for a field study of local PT calibration to assess their efficacy.

Keywords

Prothrombin time - International Normalized Ratio - thromboplastin - oral anticoagulant control - lyophilized plasma

• References

• 1 WHO Expert Committee on Biological Standardization. Thirty-third Report. WHO Tech Rep Ser 1983; 687: 81-105.
• 2 Holland LJ, Lawrie AS, Hunt BJ. Evidence of discrepant commercial ISI assignment. Blood Coag Fibrinol 1992; 3: 493-4.
• 3 Hubbard AR, Margetts SML, Barrowcliffe TW. International Normalized Ratio determination using calibrated reference plasmas. Br J Haematol 1997; 98: 74-8.
• 4 Houbouyan LL, Goguel AF. Long-term French experience in INR standardization by a procedure using plasma calibrants. Am J Clin Pathol 1997; 108: 83-9.
• 5 Van den Besselaar AMHP, Houbouyan LL, Aillaud MF, Denson KWE, Johnston M, Kitchen S, Lindahl TL, Marren M, Martinuzzo ME, Droullé C, Tripodi A, Vergnes C. Influence of three types of automated coagulometers on the International Sensitivity Index (ISI) of rabbit, human, and recombinant human tissue factor preparations. A multicenter study. Thromb Haemost 1999; 81: 66-70.
• 6 Lang H, Spaethe R, Beeser H, Becker U, Kolde HJ, Spanuth E, Witt P, Zaugg H. Calibration of a lyophilized pooled plasma as candidate reference plasma for standardization of the prothrombin time ratio. Hämostaseologie 1993; 13: 96-105.
• 7 Van den Besselaar AMHP. Multi-center study of replacement of the international reference preparation for thromboplastin, rabbit, plain. Thromb Haemost 1993; 70: 794-9.
• 8 D’Angelo A, Galli L, Lang H. Comparison of mean normal prothrombin time (PT) with PT of fresh normal pooled plasma or of a lyophilized control plasma (R82A) as denominator to express PT results: collaborative study of the International Federation of Clinical Chemistry. Clin Chem 1997; 43: 2169-74.
• 9 Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, plain. Thromb Haemost 1998; 79: 439-43.
• 10 Van den Besselaar AMHP, Meeuwisse-Braun J, Witteveen E, Van Meegen E. Effect of evacuated blood collection tubes on thromboplastin calibration. Thromb Haemost 1998; 79: 1062-3.
• 11 Tomenson JA. A statistician’s independent evaluation. In: Van den Besselaar AMHP, Gralnick HR, Lewis SM. eds. Thromboplastin calibration and oral anticoagulant control. Boston: Martinus Nijhoff Publishers; 1984: 87-108.
• 12 Preston FE. Quality control and oral anticoagulation. Thromb Haemost 1995; 74: 515-20.
• 13 Kitchen S, Jennings I, Woods TAL, Walker ID, Preston FE. Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of International Normalised Ratio: a thirty-three-laboratory collaborative study. Thromb Haemost 1996; 76: 372-6.
• 14 Duncan EM, Casey CR, Duncan BM, Lloyd JV. Effect of concentration of trisodium citrate anticoagulant on calculation of the international normalised ratio and the international sensitivity index of thromboplastin. Thromb Haemost 1994; 72: 84-8.
• 15 Chantarangkul V, Tripodi A, Clerici M, Negri B, Mannucci PM. Assessment of the influence of citrate concentration on the international normalized ratio (INR) determined with twelve reagent-instrument combinations. Thromb Haemost 1998; 80: 258-62.
• 16 Poller L, Triplett DA, Hirsh J, Carroll J, Clarke K. The value of plasma calibrants in correcting coagulometer effects on international normalized ratios. Am J Clin Pathol 1995; 103: 358-65.
• 17 Stevenson KJ, Craig S, Dufty JMK, Taberner DA. System ISI calibration: a universally applicable scheme is possible only when coumarin plasma calibrants are used. Br J Haematol 1997; 96: 435-41.
• 18 Critchfield GC, Bennett ST, Swaim WR. Calibration verification of the International Normalized Ratio. Am J Clin Pathol 1996; 106: 786-94.
• 19 Van den Besselaar AMHP. Field study of lyophilised plasmas for local prothrombin time calibration in the Netherlands. J Clin Pathol 1997; 50: 371-4.
• 20 Hubbard AR, Margetts SML, Weller LJ, Macnab J, Barrowcliffe TW. An international collaborative study on the INR calibration of freeze-dried reference plasmas. Br J Haematol 1999; 104: 455-60.